Navkiran K Shokar1, Sally W Vernon, Carol A Carlson. 1. Department of Family and Community Medicine, Texas Tech University Health Sciences Center, El Paso TX 79912, USA. navkiran.shokar@ttuhsc.edu
Abstract
OBJECTIVE: Prevalence of colorectal cancer (CRC) screening is ascertained by self-reported screening, yet little is known about the accuracy of this method across different racial/ethnic groups, particularly Hispanics. The purpose of this study was to compare the accuracy of CRC self-report measures across three racial/ethnic groups. METHODS: During 2004 and 2005, 271 white, African-American and Hispanic participants were recruited from a primary care clinic in Southeast Texas, and their CRC testing history based on self-report and medical record (the 'gold standard') were compared. RESULTS: Over-reporting was prevalent. Overall, up-to-date CRC test use was 57.6% by self-report and 43.9% by medical record. Racial/ethnic group differences were most pronounced for Hispanics in whom sensitivity was significantly lower for any up-to-date testing, fecal occult blood testing, flexible sigmoidoscopy and double contrast barium enema. There were no statistically significant differences across groups for over-reporting, specificity or concordance. CONCLUSIONS: Self-report prevalence data are overestimating CRC test use in all groups; current measures are less sensitive in Hispanics.
OBJECTIVE: Prevalence of colorectal cancer (CRC) screening is ascertained by self-reported screening, yet little is known about the accuracy of this method across different racial/ethnic groups, particularly Hispanics. The purpose of this study was to compare the accuracy of CRC self-report measures across three racial/ethnic groups. METHODS: During 2004 and 2005, 271 white, African-American and Hispanic participants were recruited from a primary care clinic in Southeast Texas, and their CRC testing history based on self-report and medical record (the 'gold standard') were compared. RESULTS: Over-reporting was prevalent. Overall, up-to-date CRC test use was 57.6% by self-report and 43.9% by medical record. Racial/ethnic group differences were most pronounced for Hispanics in whom sensitivity was significantly lower for any up-to-date testing, fecal occult blood testing, flexible sigmoidoscopy and double contrast barium enema. There were no statistically significant differences across groups for over-reporting, specificity or concordance. CONCLUSIONS: Self-report prevalence data are overestimating CRC test use in all groups; current measures are less sensitive in Hispanics.
Authors: Sally W Vernon; Helen Meissner; Carrie Klabunde; Barbara K Rimer; Dennis J Ahnen; Roshan Bastani; Margaret T Mandelson; Marion R Nadel; Sherri Sheinfeld-Gorin; Jane Zapka Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-06 Impact factor: 4.254
Authors: Diana M Tisnado; John L Adams; Honghu Liu; Cheryl L Damberg; Wen-Pin Chen; Fang Ashlee Hu; David M Carlisle; Carol M Mangione; Katherine L Kahn Journal: Med Care Date: 2006-02 Impact factor: 2.983
Authors: M Baier; N Calonge; G Cutter; M McClatchey; S Schoentgen; S Hines; A Marcus; D Ahnen Journal: Cancer Epidemiol Biomarkers Prev Date: 2000-02 Impact factor: 4.254
Authors: Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr Journal: Ann Intern Med Date: 2002-07-16 Impact factor: 25.391
Authors: Arica White; Sally W Vernon; Jan M Eberth; Jasmin A Tiro; Sharon P Coan; Peter N Abotchie; Anthony Greisinger Journal: Open J Epidemiol Date: 2013-02
Authors: Paul L Reiter; Mira L Katz; Jill M Oliveri; Gregory S Young; Adana A Llanos; Electra D Paskett Journal: Public Health Nurs Date: 2013-04-05 Impact factor: 1.462
Authors: Amanda F Petrik; Beverly B Green; William M Vollmer; Thuy Le; Barbara Bachman; Erin Keast; Jennifer Rivelli; Gloria D Coronado Journal: Fam Pract Date: 2016-07-28 Impact factor: 2.267
Authors: Maria Pisu; Cheryl L Holt; Aquila Brown-Galvan; Temeika Fairley; Judith Lee Smith; Arica White; Ingrid J Hall; Robert A Oster; Michelle Y Martin Journal: J Oncol Pract Date: 2014-01-02 Impact factor: 3.840
Authors: Jean A Shapiro; Carrie N Klabunde; Trevor D Thompson; Marion R Nadel; Laura C Seeff; Arica White Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-04-06 Impact factor: 4.254
Authors: Mira L Katz; Paul L Reiter; Gregory S Young; Michael L Pennell; Cathy M Tatum; Electra D Paskett Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-08-17 Impact factor: 4.254